About the Author(s)


Murendeni F. Sikhau symbol
Department of Family Medicine, Faculty of Health Sciences, University of Limpopo, Mankweng, South Africa

Mbuyisa J. Makhubu symbol
Department of Family Medicine, Faculty of Health Sciences, University of Limpopo, Mankweng, South Africa

Gert J.O. Marincowitz Email symbol
Department of Family Medicine, Faculty of Health Sciences, University of Limpopo, Mankweng, South Africa

Clara Marincowitz symbol
Department of Biological Sciences, Faculty of Science, University of Cape Town, Cape Town, South Africa

Citation


Sikhau MF, Makhubu MJ, Marincowitz GJO, Marincowitz C. Adherence to hypertension management at a rural hospital in Limpopo: A cross-sectional study. S Afr Fam Pract. 2025;67(1), a6136. https://doi.org/10.4102/safp.v67i1.6136

Original Research

Adherence to hypertension management at a rural hospital in Limpopo: A cross-sectional study

Murendeni F. Sikhau, Mbuyisa J. Makhubu, Gert J.O. Marincowitz, Clara Marincowitz

Received: 15 Feb. 2025; Accepted: 30 June 2025; Published: 18 Aug. 2025

Copyright: © 2025. The Author(s). Licensee: AOSIS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: Non-adherence to treatment remains a major contributing factor to uncontrolled hypertension and its complications. In South Africa, an estimated 50% of adults are living with hypertension and between 41.9% and 45.5% adhere to their treatment. Knowing reasons for non-adherence, therefore, is important in the treatment of hypertension.

Methods: A cross-sectional study involving 243 hypertensive patients was conducted from May to July 2022 at Voortrekker Hospital, Mokopane, Limpopo province. The questionnaire included socio-demographic and hypertension-related medical information and adherence was assessed using the previously validated Therapeutic Adherence Scale for Hypertensive Patients (TASHP).

Results: Forty-two per cent of participants adhered to their antihypertensive treatment, whereas 56% controlled their blood pressure. Variables such as employment (p = 0.0076), secondary and tertiary education (p = 0.0048), duration of hypertension of less than a year (p = 0.019) and level of income (more than R3000/month) (p = 0.033) were significantly associated with better adherence.

Conclusion: Adherence to treatment and blood pressure control among hypertensive patients in the Mokopane area is still inadequate, although within the same range as reported in the literature. Effective strategies must be developed to address adherence, especially for vulnerable patients.

Contribution: The study identified that only 42% of patients in a rural district hospital setting adhere to their hypertension management. Furthermore, it was found that patients less educated, unemployed, having an income of less than R3000/month or living with hypertension for more than 15 years are significantly more vulnerable to poor adherence.

Keywords: hypertension; adherence to treatment; South Africa; rural; district hospital.

Introduction

Hypertension is a major public health burden worldwide, with nearly 1.13 billion people affected. It is also a major risk factor for chronic kidney disease and cardiovascular disease, including stroke, myocardial infarction and heart failure, which are among the leading causes of global morbidity and mortality.1,2,3,4,5

The WHO global report on hypertension found that 54% of adults (30–79-years-old) with hypertension know they have condition, 42% are on treatment and only 21% of all hypertensives have their disease under control.4 There is an increased prevalence in low- and middle-income countries and this has been attributed mainly to urbanisation, an ageing population, and risk factors such as obesity and sedentary lifestyles.6,7 During the last four decades, there has been a decline in uncontrolled hypertension in high-income countries, with a significant increase in low- and middle-income countries (LMICs) in sub-Saharan Africa, South Asia, and central and Eastern Europe.4,8,9,10 In South Africa, an estimated 50% of adults are living with hypertension.11 A study by Woodiwiss et al. found that in South Africa 49.2% of hypertensives were receiving medication and only 57.5% of individuals receiving antihypertensive medication had controlled blood pressure (BP). The proportion of all hypertensives with controlled BP was only 28.3%.12

Hypertension awareness, treatment and control remain inadequate worldwide despite many advances in hypertension care.13 A major contributor to the inadequate control of hypertension is poor adherence.14,15 In Africa, non-adherence to hypertensive treatment has been reported as 62.5%.16 Adherence in Asian countries is similar to the estimated global non-adherence rate of 45.3%.16,17 Poor adherence has been attributed to socio-demographics, healthcare systems, treatment factors, people’s health conditions and patient-related factors.5,18

Dhar et al. found that 47.3% of people adhered to hypertension treatment in the 19 countries included in their review.19 Enslin et al. found in a review of South African studies an adherence rate of 41.9%.20 A survey conducted in the Vhembe District of Limpopo province found that 45.5% of hypertensive patients reported poor adherence.21

Several studies have described the importance of context-specific factors associated with adherence when planning specific interventions.16,17,18,19,20,21 There are, however, limited data from a rural South African context available on the prevalence and factors contributing to adherence and control of hypertension.20,21 The study reported here therefore aimed to assess the prevalence and factors associated with adherence to hypertensive management reported by patients attending Voortrekker Hospital, in Mokopane town, 55 km south of Polokwane, the provincial capital of Limpopo province. The hospital is situated in the Mogalakwena Local Municipality, which covers 6170.3 km2 with a population of 325 292 people. The municipality consists of 178 villages, Mahwelereng township with 41 072 people and Mokopane town with a population of 30 151. Sixty-one per cent of the population has a monthly income of less than R3000. The unemployment rate for the municipality is 40.2%. The municipality has 3 hospitals with 29 clinics. Voortrekker Hospital and its 9 clinics serve a population of 126 717, mostly living in rural villages and Mokopane town and Mahwelereng township.22

Methods

A quantitative, cross-sectional descriptive study was conducted from May to July 2022 in the outpatient department (OPD) of Voortrekker Hospital. The sample size was calculated at 240, considering a study population of 600 hypertensive patients receiving treatment at Voortrekker Hospital using the Yamane formula with a margin of error of 5%.23 Consecutive, consenting adult, hypertensive patients 18 years and older, who were on one or more antihypertensive agents for at least 6 months and attended the OPD during the study period, were included until the required number of participants was reached. Those too sick to participate, or who were mentally incapable of giving consent, pregnant or on treatment for less than 6 months, were excluded. None of the patients selected to participate refused.

Data collection

A modified, validated Therapeutic Adherence Scale for Hypertensive Patients (TASHP) questionnaire was used to collect data.24,25 This instrument included questions about adherence to medication and lifestyle factors such as diet, exercise, stress management, tobacco and alcohol use and also the frequency of BP monitoring. The instrument included 25 questions (see Table 1). A 5-point Likert response scale was used for each item, and reverse scores were assigned to negative questions, with a score of 5 being the most desirable measure. The maximum score was 125. A score of less than 109 was considered poor adherence and 109 or more was regarded as good. In addition to the 25 adherence questions, there was a section on demographic and medical data.

TABLE 1: Therapeutic adherence scale for hypertensive patients questions.

Besides English, a language expert translated the questionnaire into two other languages commonly used in the Mokopane area (Sepedi and Xitsonga). A pilot study tested the data collection tool on 20 patients from another nearby institution and was thereby confirmed as suitable and no changes were made to the original questionnaire. The results from the pilot study were not included in this research. Participants were individually seen by the research assistant, who was fluent in all languages spoken in the Mokopane area. After the study procedure was explained and written consent was obtained from potential participants who met the eligibility criteria, the research assistant administered the questionnaires to the participants. To improve reliability and reduce bias, the research assistant was trained to use the TASHP questionnaire with Likert scale questions. She was not a health worker employed at the hospital, which enhanced reliability and participants were encouraged to feel free to give honest answers without a fear of influencing their management at the hospital. Participants’ BP was measured using the same digital and calibrated Dinamap BP monitor, after resting the subject for at least 3 min before the measurement, who was seated with the back supported, the full arm bare and resting on a surface at the level of the heart with an appropriate cuff size.26 The BP reading was repeated a second time if recorded higher than 140/90. After the questionnaire was completed, patients were taken to the doctor for consultation.

Data analysis

At the end of each day, the data were captured on an Excel spreadsheet, which were then checked and cleaned. The data included the 25 adherence questions (see Table 1), demographic data, disease information and BP readings (see Table 2). Participants with BP of 140/90 mmHg or less were considered controlled in the context of this study. Descriptive statistics of the patients’ demographic data were summarised as frequencies and percentages and presented in charts and a table. A chi-squared test was used to identify the association between demographic information and adherence to hypertensive management. A p-value of 0.05 or less was considered statistically significant. IBM Statistical Package for the Social Sciences (SPSS) version 28.0 was used for the analysis.

TABLE 2: Demographics of study population and factors of adherence.
Ethical considerations

Ethical clearance was obtained from the Turfloop (University of Limpopo) Research and Ethics Committee on 29 March 2022 (TREC/52/2022:PG). Permission to conduct the research was then granted by the Limpopo Department of Health (LP_2023_06_004), the Waterberg District Health Authority and by the CEO of Voortrekker Hospital. No patient identifiers were used when information was captured to ensure privacy and confidentiality.

Results

Questionnaires were completed by 243 patients, 60% of whom were female, 58% were married, 63% were older than 60 years, and 46% had secondary school as their highest level of education. Fifty-four per cent of participants resided in rural areas, and 66% had to travel 5 km – 10 km to the healthcare facility. Sixty-four per cent of participants were receiving a social grant and 83% had a monthly income of less than R3000. Forty-three per cent had been on hypertension treatment for more than 10 years, whereas 14% had received it for less than a year. Sixty-seven per cent of the participants also had other medical conditions, and 50% were taking two antihypertensive drugs (see Table 2).

Fifty-six per cent of the participants had BP of 140/90 or less and were considered controlled. Fifty-eight per cent of the participants scored less than 109/125 on the TASHP questionnaire. A score of 109 or more out of a possible 125 (see Table 1) is considered adherent.24,25 Cronbach’s alpha, used to measure the reliability of the questionnaire, was 0.61, indicating an acceptable level of internal consistency.

Four factors were significantly associated with poor adherence, namely, being unemployed (p = 0.0076), having a monthly income of less than R3000 (p = 0.033); having a relatively low level of education (p = 0.0048) and having had hypertension for more than 15 years (p = 0.019) (Table 2). Factors such as age, gender, place of residence, marital status, distance to care, duration of HPT treatment, number of drugs taken, BP control and comorbidities were not found to be statistically significantly associated with adherence.

Discussion

Our study was carried out in a single public sector district hospital outpatient department serving a population from either rural villages, the township or town in Limpopo Province. We found that 58% of the participants reported inadequate adherence to their hypertensive management and 56% were found to have controlled BP. Our subjects comprised mainly rural, elderly people, on grants, who were unemployed or with inadequate minimum monthly incomes. The study population of patients accessing hypertensive care at the hospital is skewed towards patients with a little more resources, as the poorest of the poor would access care at their local clinics.

Our study also indicated that 42% of the participants reported adequately adhering to antihypertensive management. Similar trends were found in a study conducted in Saudi Arabia, where 42% of 306 patients adhered to treatment.27 The adherence rate in our study was slightly higher than that reported in Africa (34.1%) and elsewhere in South Africa (36.3%).6,28

We found that 56% of our participants had controlled BP, which was in similar range as the literature. Woodiwiss et al. found in South Africa that 57.5% of individuals receiving antihypertensive medication had controlled BP.12 In Sedibeng, South Africa, BP was controlled in 50.2% of the respondents.28 Feng et al.29 reported a hypertension control rate of 64.4% in rural China. Ni et al. reported a hypertensive control rate of 32.3%30 in Shenzhen, China. The latter is similar to the Beaney et al.’s study31 that assessed hypertension control in 92 countries, which found a hypertension control rate of 31.7%.31 There is the possibility that the population of patients coming to the hospital for care are more adherent to treatment as they have easier access than those in distant villages. Our findings indicated that 80.7% of participants were living less than 10 km from the hospital.

We found no statistically significant association between BP control and adherence. This unexpected finding could be because of the sample size and other forms of bias introduced by the convenient sampling and single facility-based study. In our study, only 41% of those with controlled and 44% of those with uncontrolled BP demonstrated good adherence. This contradictory observation could be explained by the fact that inadequate treatment regimes, the presence of complications and secondary causes of hypertension could also be contributing to this result. In a hospital-based study, more participants with complicated hypertension are expected, considering referral guidelines. Khadoura et al.32 also found no statistically significant association between adherence and hypertension control in their randomised control trial performed in Gaza. In contrast, Desta et al.33 found in a meta-analysis of studies conducted in Ethiopia that patients with good adherence are significantly less likely to have poor hypertension control.

We found a statistically significant association between adherence and level of education, income and employment status. Better-educated participants had superior adherence, as reflected in several studies.1,17,28 Our findings that those patients who were unemployed, on social grants or had a monthly income of less than R3000 are significantly less inclined to follow treatment, were echoed by studies conducted in Nigeria, Kenya, Ethiopia and Indonesia.7,14,34,35

In our study, participants who had HPT for more than 15 years were significantly less likely to maintain treatment, whereas some surveys found the opposite.24,35 This could be because most of our subjects who were on treatment for many years, with complicated treatment regimes, suffered treatment fatigue.36 It could also be that poor insight and limited knowledge about their condition, or the sheer hardship of daily living, contribute to this finding, as suggested by Hamrahian et al.18

We found no significant association between adherence and age, gender, place of residence, marital status, distance to care, duration of HPT medication, the number of drug treatments the participants were taking, BP control or the presence of comorbidities. The literature is inconclusive about several of these factors. Masilela et al.37 and Macquart de Terline et al.38 also found no definite association between gender and adherence. In contrast, Pan et al.24 found that women were significantly better at adherence. Several studies found an association between advanced age and poor adherence,32,36,39,40 which is contrary to Choi et al.,41 who found better adherence in older people. The literature generally supports the notion that distance from health facilities makes a difference to people’s adherence.7,14 However, Algabbani and Algabbani27 found that, in Saudi Arabia, distance to care facilities was not associated with better adherence to treatment.

Conclusion

Adherence to treatment was 42% and BP control was 56% among hypertensive patients in the Mokopane area lying within the same range as reported in the literature. Research is needed to evaluate adherence and BP control at community level, as a hospital-based study could be biased towards the more adherent patients. More research is also needed to understand the lack of correlation between treatment adherence and BP control.

Because most patients attending public health facilities in South Africa are unemployed, on a social grant, or with a monthly income below R3000, poor adherence is a serious threat to effective patient care in our setting. A concerted effort should be made to care for these vulnerable patients to improve their adherence to treatment and enhance control of their hypertension. Hamrahian et al.18 suggested that the secret to improved adherence to treatment lies in patient-centred, respectful and compassionate health worker–patient relationships, in addition to sustained efforts to improve patients’ understanding of their condition and involvement in their care through personalised BP monitoring.18

Limitations

This study has limitations, as do all cross-sectional surveys. It was carried out at a single institution and thus the results are not generalisable. We used consecutive sampling, which is a weak way of selecting a study population, and included only hypertensive patients who were available at the time our subjects were selected. Self-reported questionnaires are susceptible to recall bias by either over-reporting or under-reporting past health behaviour or inability to remember past medical information. Other factors recorded in the literature to influence adherence, such as the health system our patients experienced, patient–doctor relationships, self-efficacy, social support and self-care, were not explored.

Acknowledgements

The research findings as presented in this article was originally presented at the South African Academy of Family Physicians’ 26th Annual National Family Practitioners Congress, held in Protea Breakwater Lody, on 07–08 September 2024. The conference presentation, titled ‘Adherence to Hypertensive management in adult patients at Voortrekker Hospital, Mokopane, Limpopo Province’, was subsequently expanded and revised for this journal publication. This republication is done with permission from the conference organisers.

This article is based on research originally conducted as part of Murendeni F. Sikhau’s master’s thesis titled ‘Factors associated with adherence to hypertensive management in adult patients seen at Voortrekker hospital, Mokopane, Limpopo, submitted to the Department of Family Medicine, University of Limpopo.

The thesis is currently unpublished and not publicly available. The thesis was supervised by Mbuyisa James Makhubu and Gert Jan Oosthuizen Marincowitz. The manuscript has been revised and adapted for journal publication. The author confirms that the content has not been previously published or disseminated and complies with ethical standards for original publication. The author would also like to acknowledge Itumeleng Kekana, who was research assistant in this research

Competing interests

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Authors’ contributions

M.F.S. conducted this research as part of her master’s degree in medicine (family medicine) studies, M.J. was the research supervisor, and G.J.O.M. was the co-supervisor, assisted with the original dissertation, provided feedback and assisted with the writing of the article. C.M. critically reviewed the manuscript.

Funding information

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Data availability

Data sharing is not applicable to this article as no new data were created or analysed in this study.

Disclaimer

The views and opinions expressed in this article are those of the authors and are the product of professional research. They do not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article’s results, findings and content.

References

  1. Madela SL, Harriman NW, Sewpaul R, et al. Individual and area-level socioeconomic correlates of hypertension prevalence, awareness, treatment, and control in uMgungundlovu, KwaZulu-Natal, South Africa. BMC Public Health. 2023;23(1):417. https://doi.org/10.1186/s12889-023-15247-0
  2. Sarfo FS, Mobula LM, Burnham G, et al. Factors associated with uncontrolled blood pressure among Ghanaians: Evidence from a multicenter hospital-based study. PLoS One. 2018;13(3):e0193494. https://doi.org/10.1371/journal.pone.0193494
  3. Aberhe W, Mariye T, Bahrey D, et al. Prevalence and factors associated with uncontrolled hypertension among adult hypertensive patients on follow-up at Northern Ethiopia, 2019: Cross-sectional study. Pan Afr Med J. 2020;36(1):187. https://doi.org/10.1155/2020/8896990
  4. Global report on hypertension: The race against a silent killer. Geneva: World Health Organization; 2023.
  5. Burnier M, Egan BM. Adherence in hypertension: A review of prevalence, risk factors, impact, and management. Circ Res. 2019;124(7):1124–1140. https://doi.org/10.1161/CIRCRESAHA.118.313220
  6. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785–802. https://doi.org/10.1038/s41569-021-00559-8
  7. Moss JT, Kimani H, Mwanzo I. Compliance to antihypertensive therapy and associated factors among adults’ hypertensive patients attending medical clinics in Kilifi County Kenya. Int J Commun Med Public Health. 2021;8(10):4655–4665. https://doi.org/10.18203/2394-6040.ijcmph20213758
  8. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. https://doi.org/10.1016/S0140-6736(21)01330-1
  9. Brunström M, Burnier M, Grassi G, et al. ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023;41:1874–2071.
  10. Nguyen TN, Chow CK. Global and national high blood pressure burden and control. Lancet. 2021;398(10304):932–933. https://doi.org/10.1016/S0140-6736(21)01688-3
  11. The Heart and Stroke Foundation South Africa. World Hypertension Day Fact Sheet. 2021 [cited n.d.]. Available from: https://heartfoundation.co.za/wp-content/uploads/2021/05/World-Hypertension-Day-Fact-Sheet-2021.docx-2.pdf
  12. Woodiwiss AJ, Kruger R, Norton GR, et al. May measurement month 2018: An analysis of blood pressure screening results in South Africa. Eur Heart J Suppl. 2020;22(suppl H):H115–H118. https://doi.org/10.1093/eurheartj/suaa043
  13. Dalal JJ, Kerkar P, Guha S, et al. Therapeutic adherence in hypertension: Current evidence and expert opinion from India. Indian Heart J. 2021;73(6):667–673. https://doi.org/10.1016/j.ihj.2021.09.003
  14. Bekele F, Fekadu G, Dugassa D, Bekele K. Non-compliance and its associated factors among hypertensive patients taking anti-hypertensive treatment visiting Gimbi general hospital, Western Ethiopia: Cross-sectional study. Res Sq. 2019. https://doi.org/10.21203/rs.2.10283/v1
  15. Pareja-Martinez E, Esquivel-Prados E, Martinez-Martinez F, Garcia-Corpas JP. Questionnaires on adherence to antihypertensive treatment: A systematic review of published questionnaires and their psychometric properties. Int J Clin Pharm. 2020;42:355–365. https://doi.org/10.1007/s11096-020-00981-x
  16. Kang GC, Koh EY, Tan NC. Prevalence and factors associated with adherence to anti-hypertensives among adults with hypertension in a developed Asian community: A cross-sectional study. Proc Singap Healthc. 2020;29(3):167–175. https://doi.org/10.1177/2010105820933305
  17. Shin J, Konlan KD. Prevalence and determinants of medication adherence among patients taking antihypertensive medications in Africa: A systematic review and meta-analysis 2010–2021. Nurs Open. 2023;10(6):3506–3518. https://doi.org/10.1002/nop2.1613
  18. Hamrahian SM, Maarouf OH, Fülöp T. A critical review of medication adherence in hypertension: Barriers and facilitators clinicians should consider. Patient Prefer Adher. 2022;2022::2749–2757. https://doi.org/10.2147/PPA.S368784
  19. Dhar L, Earnest J, Ali M. A systematic review of factors influencing medication adherence to hypertension treatment in developing countries. Open J Epidemiol. 2017;7(3):211–250. https://doi.org/10.4236/ojepi.2017.73018
  20. Enslin D, Mallya P. Factors influencing treatment adherence in hypertension and HIV management in South Africa: A comparative literature review. S Afr Fam Pract. 2022;64(3):a5434. https://doi.org/10.4102/safp.v64i1.5434
  21. Rampamba EM, Meyer JC, Godman B, Kurdi A, Helberg E. Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa. J Comp Eff Res. 2018;7(7):661–672. https://doi.org/10.2217/cer-2018-0004
  22. Republic of South Africa. Department of Cooperative Governance and Traditional Affairs. Profile: Waterberg District. 2020 [cited n.d.]. Available from: https://www.cogta.gov.za/cgta_2016/wp-content/uploads/2023/11/Take2_2020.06.15-WATERBERG-DISTRICT-PROFILE-Edited-Version-final_V1.pdf
  23. Yamane T. Statistics: An introductory analysis. 2nd ed. New York, NY: Harper & Row; 1967.
  24. Pan J, Wu L, Wang H, et al. Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients. Medicine. 2019;98(27):e16116. https://doi.org/10.1097/MD.0000000000016116
  25. Tang HY, Zhu JC, He HY, Qian C, Yang Y. Development and evaluation of a new therapeutic adherence scale for hypertensive patients. J Third Military Med Univ. 2011;33(13):1400–1402.
  26. Zheng Y, Cai GY, Chen XM. The enlightenment and thinking of the ISH 2020 global hypertension practice guidelines on the management of renal hypertension in China. Natl Med J China [Zhonghua yi xue za zhi]. 2020;100(42):3281–3284.
  27. Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: Findings from a cross-sectional study. Clin Hypertens. 2020;26:1–9. https://doi.org/10.1186/s40885-020-00151-1
  28. Onwukwe SC, Ngene NC. Blood pressure control in hypertensive patients attending a rural community health centre in Gauteng Province, South Africa: A cross-sectional study. S Afr Fam Pract. 2022;64(2):a5403. https://doi.org/10.4102/safp.v64i1.5403
  29. Feng Y, Guan S, Xu Y, et al. Effects of the two-dimensional structure of trust on patient adherence to medication and non-pharmaceutical treatment: A cross-sectional study of rural patients with essential hypertension in China. Front Public Health. 2022;10:818426. https://doi.org/10.3389/fpubh.2022.818426
  30. Ni W, Yuan X, Zhang J, et al. Factors associated with treatment and control of hypertension among elderly adults in Shenzhen, China: A large-scale cross-sectional study. BMJ Open. 2021;11(8):e044892. https://doi.org/10.1136/bmjopen-2020-044892
  31. Beaney T, Schutte AE, Stergiou GS, et al. May measurement month 2019: The global blood pressure screening campaign of the International Society of Hypertension. Hypertension. 2020;76(2):333–341. https://doi.org/10.1161/HYPERTENSIONAHA.120.14874
  32. Khadoura K, Shakibazadeh E, Mansournia MA, Aljeesh Y, Fotouhi A. Determining the prevalence of and the factors associated with antihypertensive medication non-adherence in the Gaza Strip. Korean J Fam Med. 2021;42(2):150. https://doi.org/10.4082/kjfm.19.0081
  33. Desta M, Yibeltal D, Memiah P, et al. Antihypertensive medications adherence and associated uncontrolled blood pressure among hypertensive patients in Ethiopia: Systematic review and meta-analysis. Int J Afr Nurs Sci. 2022;16:100404. https://doi.org/10.1016/j.ijans.2022.100404
  34. Azeez IA, Olubayo AM, Adeyemo KA. Prevalence and predictors of dyslipidemia among hypertensive patients attending a secondary healthcare center in southwestern Nigeria. Saudi J Obes. 2019;7(1):21–28. https://doi.org/10.4103/sjo.SJO_3_22
  35. Visuddho V, Kurniawan PA, Rafidah SF, et al. Determinant factors of treatment adherence of hypertensive patients in a rural area of Indonesia. J ID Health. 2023;6(2):854–860. https://doi.org/10.47108/jidhealth.Vol6.Iss2.281
  36. Heckman BW, Mathew AR, Carpenter MJ. Treatment burden and treatment fatigue as barriers to health. Curr Opin Psychol. 2015;5:31–36. https://doi.org/10.1016/j.copsyc.2015.03.004
  37. Masilela C, Pearce B, Ongole JJ, Adeniyi OV, Benjeddou M. Cross-sectional study of prevalence and determinants of uncontrolled hypertension among South African adult residents of Mkhondo municipality. BMC Public Health. 2020;20:1–10. https://doi.org/10.1186/s12889-020-09174-7
  38. Macquart De Terline D, Kane A, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income sub-Saharan countries. PLoS One. 2019;14(7):e0219266. https://doi.org/10.1371/journal.pone.0219266
  39. Shah AJ, Singh V, Patil SP, Gadkari MR, Ramchandani V, Doshi KJ. Factors affecting compliance to antihypertensive treatment among adults in a tertiary care hospital in Mumbai. Indian J Community Med. 2018;43(1):53–55. https://doi.org/10.4103/ijcm.IJCM_40_17
  40. Foti K, Matsushita K, Koton S, et al. Changes in hypertension control in a community-based population of older adults, 2011–2013 to 2016–2017. Am J Hypertens. 2021;34(6):591–599. https://doi.org/10.1093/ajh/hpaa206
  41. Choi HY, Lee JA, Lim J, et al. Factors affecting adherence to antihypertensive medication. Korean J Fam Med. 2018;39(6):325. https://doi.org/10.4082/kjfm.17.0041


Crossref Citations

No related citations found.